EBD Group Release: BioPharm America™ 2013 Program Leads with Plenary on Drug Development Pipeline “The Chameleon Rubik’s Cube”

Published: Jun 07, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOSTON & CARLSBAD, Calif. & WASHINGTON--(BUSINESS WIRE)--EBD Group’s BioPharm America™ will kick off its 2013 program with an Opening Plenary entitled “Strategic R&D Planning: The Chameleon Rubik’s Cube” on Tuesday, September 17. The plenary features moderator Vaughn Kailian, Managing Director of MPM Capital and includes speakers James Hoyes, President of EMD Serono; David Meeker, CEO of Genzyme; and Roger Pomerantz, Senior VP and Head, Worldwide Licensing and Acquisitions at Merck. The panel will discuss long-term pipeline planning in drug development which can be likened to a Rubik’s cube that changes colors with its surroundings.

Help employers find you! Check out all the jobs and post your resume.

Back to news